{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P23510",
      "entity_text" : "OX40L",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "OX40L blockade through gene invalidation or targeted therapy using monoclonal antibodies prevented and induced regression of established inflammation driven dermal fibrosis in the bleomycin mouse model, which mimics early and inflammatory stages of SSc.",
  "reading_complete" : "2020-08-04T12:15:51Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:14:49Z",
  "trigger" : "prevented",
  "evidence" : [ "OX40L blockade through gene invalidation or targeted therapy using monoclonal antibodies prevented and induced regression of established inflammation" ],
  "pmc_id" : "6305435",
  "score" : 0
}